Skip to main content

On Miles O'Brien

By Eric McErlain
One reporter we follow very closely is PBS science reporter Miles O'Brien. He's reported a number of stories on the nuclear industry in the wake of Fukushima, including a November 2011 Frontline documentary called "Nuclear Aftershocks." As my colleague John Keeley noted in 2011, "O’Brien is a solid journo with a reputation for resisting the melodramatic and sensational in favor of substantive and balanced pieces."

Needless to say we were shocked and concerned when O'Brien reported on his own website that a freak accident had resulted in doctors having to amputate his left forearm just above the elbow. Apparently, O'Brien is back in the U.S. and doing his level best to adjust to a new reality. The good news: despite the accident, O'Brien seems to be facing his disability with resolve, determination and even a little bit of humor.
So I woke up to a new reality in the hospital. It’s been a challenging week dealing with the phantom pain, the vicissitudes of daily life with one hand and the worries about what lies ahead.

But I am alive and I’m grateful for that. Please don’t worry about me. I’m sure I can cope just fine. If I need your help, I promise I will ask.

Life is all about playing the hand that is dealt you. Actually, I would love somebody to deal me another hand right about now – in more ways than one.
Best wishes to O'Brien in all of the challenges ahead.
Labels:

Comments

Post a Comment

Popular posts from this blog

Fluor Invests in NuScale

By
You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...
1 comment
Read more

Wednesday Update

By
From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...
Post a Comment
Read more

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

By
Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...
Post a Comment
Read more